---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-010568"
form_type: "8-K"
ticker: "PURE"
cik: "0001006028"
company_name: "PURE BIOSCIENCE, INC."
filed_at: "2025-03-17T23:59:59+00:00"
generated_at: "2026-05-24T14:53:47.466380+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# PURE Bioscience Q2 net sales up 20% YoY to $391K; net loss narrows to $798K

## Summary
- Net product sales $391K for fiscal Q2 ended Jan 31, 2025, vs $325K a year ago (+20%).
- Net loss $798K vs $1,002K in prior-year quarter; loss per share unchanged at ($0.01).
- SG&A expenses fell $194K due to reductions in personnel, professional fees, and stock comp.
- Company advanced dairy membrane solutions to full-scale in-plant pilots with a large distribution partner.
- Pilot data shows benefits in water/energy savings, fouling removal, and reduced downtime for dairy ops.

## SEC filing metadata
- accession: 0001493152-25-010568
- form_type: 8-K
- ticker: PURE
- cik: 0001006028
- company_name: PURE BIOSCIENCE, INC.
- filed_at: 2025-03-17T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006028/000149315225010568/0001493152-25-010568-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006028/000149315225010568/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-010568
- JSON: https://secwatch.observer/filing/0001493152-25-010568.json
- Plain text: https://secwatch.observer/filing/0001493152-25-010568.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.